# Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies

> **NCT00013533** · EARLY_PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 30 (actual)

## Conditions studied

- Hodgkin Lymphoma
- Lymphocytic Leukemia
- Mixed Cell Leukemia
- Myelodysplastic Syndrome
- Non Hodgkin's Lymphoma
- CML
- ALL
- AML
- Lymphoma

## Interventions

- **PROCEDURE:** Stem cell transplantation

## Key facts

- **NCT ID:** NCT00013533
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-03-14
- **Primary completion:** 2008-03-01
- **Final completion:** 2015-05-07
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00013533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00013533, "Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00013533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*